Search for Clinical Trial Results
Paraganglioma, Extra-Adrenal - 25 Studies Found
Status | Study |
Available |
Study Name: 18F-FDOPA PET in Neuroendocrine Tumours Condition:
|
Active, not recruiting |
Study Name: Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation Condition:
Date: 2014-06-04 Interventions: Other: PET-CT |
Recruiting |
Study Name: Evaluation of Gallium-68 DOTA-TOC Imaging of Somatostatin Receptor Positive Malignancies Condition:
Date: 2014-06-25 Interventions: Drug: DOTA-TOC PET/CT Single Gallium-68 DOTA-TOC PET/CT in patients with somatostatin receptor positive |
Active, not recruiting |
Study Name: Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma Condition:
Date: 2013-10-19 Interventions: Drug: Axitinib (AG-013736) Axitinib will be given as self-administered oral doses at the initial level o |
Available |
Study Name: Expanded Access Protocol Using 131I-MIBG Therapy for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma Condition:
Date: 2013-04-08 Interventions: Radiation: I-131 MIBG The therapeutic dose (5-18 mCi/kg at investigator's discretion; any dose ≥12 |
Active, not recruiting |
Study Name: Dovitinib in Neuroendocrine Tumors Condition:
Date: 2012-05-01 Interventions: Radiation: I-131 MIBG The therapeutic dose (5-18 mCi/kg at investigator's discretion; any dose ≥12 |
Completed |
Study Name: Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors Condition:
|
Completed |
Study Name: A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors Condition:
Date: 2011-08-08 Interventions: Radiation: 131I-MIBG Therapeutic 131I-MIBG will be synthesized at Nuclear Diagnostic Products (NDP; Rock |
Available |
Study Name: Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma Condition:
Date: 2011-06-13 Interventions: Drug: 131 I-Metaiodobenzylguanidine (131 I-MIBG) Therapeutic 131I-MIBG will be synthesized at Nuclear Di |